The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

• Published in: Neuroscience and biobehavioral reviews Vol. 78; pp. 44 - 56
• Main Authors: Skvarc, David R., Dean, Olivia M., Byrne, Linda K., Gray, Laura, Lane, Stephen, Lewis, Matthew, Fernandes, Brisa S., Berk, Michael, Marriott, Andrew
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.07.2017
• Subjects: Acetylcysteine; Antioxidant; Antioxidants; Cognition; dementia; Executive function; Glutathione; Humans; Inflammation; N-acetylcysteine; Neuropsychology; Oxidative Stress; Post-operative cognitive dysfunction; Oxidative stress; Executive function; dementia; Cognition; Inflammation; Post-operative cognitive dysfunction; Neuropsychology; Antioxidant; N-acetylcysteine
• ISSN: 0149-7634; 1873-7528
• DOI: 10.1016/j.neubiorev.2017.04.013

•Oxidation and neuroinflammation modulate cognition through a variety of vectors.•NAC mitigates the cognitive effects of neuroinflammation in animals.•Evidence that NAC can modulate human cognition is promising but inconsistent.•Combined antioxidants are effective, but the specific contribution of NAC is unknown.•Further exploration of NAC’s ability to modify cognitive change is warranted. Oxidative stress, neuroinflammation and neurogenesis are commonly implicated as cognitive modulators across a range of disorders. N-acetylcysteine (NAC) is a glutathione precursor with potent antioxidant, pro-neurogenesis and anti-inflammatory properties and a favourable safety profile. A systematic review of the literature specifically examining the effect of NAC administration on human cognition revealed twelve suitable articles for inclusion: four examining Alzheimer's disease; three examining healthy participants; two examining physical trauma; one examining bipolar disorder, one examining schizophrenia, and one examining ketamine-induced psychosis. Heterogeneity of studies, insufficiently powered studies, infrequency of cognition as a primary outcome, heterogeneous methodologies, formulations, co-administered treatments, administration regimes, and assessment confounded the drawing of firm conclusions. The available data suggested statistically significant cognitive improvements following NAC treatment, though the paucity of NAC-specific research makes it difficult to determine if this effect is meaningful. While NAC may have a positive cognitive effect in a variety of contexts; larger, targeted studies are warranted, specifically evaluating its role in other clinical disorders with cognitive sequelae resulting from oxidative stress and neuroinflammation.